Andexanet Alfa for Factor Xa Inhibitor Reversal

Joseph J. Shatzel; Molly M. Daughety; Thomas G. DeLoughery

doi:10.1056/NEJMc1613270

Andexanet Alfa for Factor Xa Inhibitor Reversal

Joseph J. Shatzel, Molly M. Daughety, Thomas G. DeLoughery

Hematology & Medical Oncology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	2499
Number of pages	1
Journal	The New England journal of medicine
Volume	375
Issue number	25
DOIs	https://doi.org/10.1056/NEJMc1613270
State	Published - Dec 22 2016

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJMc1613270

Cite this

@article{bea38ca7d8574202898767308cc9e8ce,

title = "Andexanet Alfa for Factor Xa Inhibitor Reversal",

author = "Shatzel, {Joseph J.} and Daughety, {Molly M.} and DeLoughery, {Thomas G.}",

year = "2016",

month = dec,

day = "22",

doi = "10.1056/NEJMc1613270",

language = "English (US)",

volume = "375",

pages = "2499",

journal = "The New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "25",

}

TY - JOUR

T1 - Andexanet Alfa for Factor Xa Inhibitor Reversal

AU - Shatzel, Joseph J.

AU - Daughety, Molly M.

AU - DeLoughery, Thomas G.

PY - 2016/12/22

Y1 - 2016/12/22

UR - http://www.scopus.com/inward/record.url?scp=85011320909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011320909&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1613270

DO - 10.1056/NEJMc1613270

M3 - Letter

C2 - 28002712

SN - 0028-4793

VL - 375

SP - 2499

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 25

ER -

Andexanet Alfa for Factor Xa Inhibitor Reversal

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this